The company
Bone Biologics Corp
BBLG · Nasdaq
BBLG stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 61.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 3 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 23,879$33K | +23,879 |
| Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026 | 1,953$2,676 | -2,173−52.7% |
| SBI Securities Co., Ltd.unchanged · filed 23 Jul 2026 | 230$315 | 00.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.